{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:49:46Z","timestamp":1791589786391,"version":"4.3.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"DOI":"10.1038\/s41440-026-02855-7","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:50:02Z","timestamp":1791543002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypertension: a missing piece in HFpEF?"],"prefix":"10.1038","author":[{"given":"Michiaki","family":"Nagai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Dote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny S.","family":"Po","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun W.","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"2855_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41440-021-00771-6","volume":"45","author":"T Takami","year":"2022","unstructured":"Takami T, Hoshide S, Kario K. Differential impact of antihypertensive drugs on cardiovascular remodeling: a review of findings and perspectives for HFpEF prevention. Hypertens Res. 2022;45:53\u201360.","journal-title":"Hypertens Res"},{"key":"2855_CR2","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1038\/s41440-024-01886-2","volume":"47","author":"M Nagai","year":"2024","unstructured":"Nagai M, Rommel KP, Po SS, Dasari TW. Autonomic neuromodulation for cardiomyopathy associated with metabolic syndrome - Prevention of precursors for heart failure with preserved ejection fraction. Hypertens Res. 2024;47:3318\u201329.","journal-title":"Hypertens Res"},{"key":"2855_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ejhf.3506","volume":"27","author":"F Lindberg","year":"2025","unstructured":"Lindberg F, Benson L, Dahlstr\u00f6m U, Lund LH, Savarese G. Trends in heart failure mortality in Sweden between 1997 and 2022. Eur J Heart Fail. 2025;27:366\u201376.","journal-title":"Eur J Heart Fail"},{"key":"2855_CR4","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895\u2013e1032.","journal-title":"Circulation"},{"key":"2855_CR5","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1161\/CIR.0000000000001455","volume":"154","author":"MN Walsh","year":"2026","unstructured":"Walsh MN, Kober L, Sliwa K, Adamo M, Agarwal A, Banerjee A, et al. AHA\/ACC\/ESC\/WHF expert consensus document: second universal definition of heart failure (2026). Circulation. 2026;154:e279\u2013e293.","journal-title":"Circulation"},{"key":"2855_CR6","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1038\/s41440-025-02305-w","volume":"48","author":"S Wachi","year":"2025","unstructured":"Wachi S, Narita K, Fujiwara T, Komori T, Hoshide S, Kario K. Association of home blood pressure with asymptomatic Stage B heart failure determined by cardiac biomarkers. Hypertens Res. 2025;48:2654\u201363.","journal-title":"Hypertens Res"},{"key":"2855_CR7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/s41440-025-02174-3","volume":"48","author":"T Komori","year":"2025","unstructured":"Komori T, Hoshide S, Kario K. The prognostic impact of home blood pressure measurements in patients with stage B heart failure. Hypertens Res. 2025;48:1779\u201386.","journal-title":"Hypertens Res"},{"key":"2855_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129\u20132200.","journal-title":"Eur Heart J"},{"key":"2855_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"2855_CR10","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ejhf.3112","volume":"26","author":"D Tomasoni","year":"2024","unstructured":"Tomasoni D, Vitale C, Guidetti F, Ghionzoli N, Chan J, Ceravolo I, et al. The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum. Eur J Heart Fail. 2024;26:854\u201368.","journal-title":"Eur J Heart Fail"},{"key":"2855_CR11","doi-asserted-by":"publisher","first-page":"e093306","DOI":"10.1136\/bmjopen-2024-093306","volume":"15","author":"L Li","year":"2025","unstructured":"Li L, Li Z, Xu P, Zhang Y, Wu W, Chen W, et al. Comorbidities and incidence of heart failure with preserved ejection fraction: a systematic review and meta-analysis of cohort studies. BMJ Open. 2025;15:e093306.","journal-title":"BMJ Open"},{"key":"2855_CR12","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.122.320257","volume":"130","author":"J Roh","year":"2022","unstructured":"Roh J, Hill JA, Singh A, Valero-Mu\u00f1oz M, Sam F. Heart failure with preserved ejection fraction: Heterogeneous syndrome, diverse preclinical models. Circ Res. 2022;130:1906\u201325.","journal-title":"Circ Res"},{"key":"2855_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10741-024-10456-0","volume":"30","author":"JW Chang","year":"2025","unstructured":"Chang JW, Ramchandra R. The sympathetic nervous system in heart failure with preserved ejection fraction. Heart Fail Rev. 2025;30:209\u201318.","journal-title":"Heart Fail Rev"},{"key":"2855_CR14","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1161\/HYPERTENSIONAHA.125.24884","volume":"82","author":"JW Chang","year":"2025","unstructured":"Chang JW, George B, Pachen M, Shanks J, Ramchandra R. Cardiac sympathetic nerve activity is not elevated in ovine hypertensive HFpEF. Hypertension. 2025;82:1401\u201311.","journal-title":"Hypertension"},{"key":"2855_CR15","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/ejhf.945","volume":"19","author":"AS Koh","year":"2017","unstructured":"Koh AS, Tay WT, Teng THK, Vedin O, Benson L, Dahlstrom U, et al. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail. 2017;19:1624\u201334.","journal-title":"Eur J Heart Fail"},{"key":"2855_CR16","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"2855_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.repc.2025.02.007","volume":"44","author":"R Ono","year":"2025","unstructured":"Ono R, Menezes Falc\u00e3o L. Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes. Rev Port Cardiol. 2025;44:445\u201356.","journal-title":"Rev Port Cardiol"},{"key":"2855_CR18","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","volume":"118","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023;118:3434\u201350.","journal-title":"Cardiovasc Res"},{"key":"2855_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jash.2010.06.005","volume":"4","author":"K Kario","year":"2010","unstructured":"Kario K. Proposal of RAS-diuretic vs. RAS-calcium antagonist strategies in high-risk hypertension: insight from the 24-hour ambulatory blood pressure profile and central pressure. J Am Soc Hypertens. 2010;4:215\u20138.","journal-title":"J Am Soc Hypertens"},{"key":"2855_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/ajh\/hpy083","volume":"31","author":"P Martinez-Quinones","year":"2018","unstructured":"Martinez-Quinones P, McCarthy CG, Watts SW, Klee NS, Komic A, Calmasini FB, et al. Hypertension induced morphological and physiological changes in cells of the arterial wall. Am J Hypertens. 2018;31:1067\u201378.","journal-title":"Am J Hypertens"},{"key":"2855_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40885-023-00258-1","volume":"29","author":"HL Kim","year":"2023","unstructured":"Kim HL. Arterial stiffness and hypertension. Clin Hypertens. 2023;29:31.","journal-title":"Clin Hypertens"},{"key":"2855_CR22","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1093\/eurheartj\/ehy346","volume":"39","author":"T Weber","year":"2018","unstructured":"Weber T, Chirinos JA. Pulsatile arterial haemodynamics in heart failure. Eur Heart J. 2018;39:3847\u201354.","journal-title":"Eur Heart J"},{"key":"2855_CR23","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1097\/HJH.0000000000002910","volume":"39","author":"A Kasiakogias","year":"2021","unstructured":"Kasiakogias A, Rosei EA, Camafort M, Ehret G, Faconti L, Ferreira JP, et al. Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension. J Hypertens. 2021;39:1522\u201345.","journal-title":"J Hypertens"},{"key":"2855_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.acvd.2018.04.007","volume":"111","author":"Y Juilli\u00e8re","year":"2018","unstructured":"Juilli\u00e8re Y, Venner C, Filippetti L, Popovic B, Huttin O, Selton-Suty C. Heart failure with preserved ejection fraction: a systemic disease linked to multiple comorbidities, targeting new therapeutic options. Arch Cardiovasc Dis. 2018;111:766\u201381.","journal-title":"Arch Cardiovasc Dis"},{"key":"2855_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10741-026-10600-y","volume":"31","author":"MS Arshad","year":"2026","unstructured":"Arshad MS, Saad M, Lurz P, Rommel KP, Khan MS, Bangalore S, et al. Intensive blood pressure control in heart failure with preserved ejection fraction: a symptom-modifying strategy. Heart Fail Rev. 2026;31:31.","journal-title":"Heart Fail Rev"},{"key":"2855_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","volume":"39","author":"JGF Cleland","year":"2018","unstructured":"Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, et al. Beta-blockers in Heart Failure Collaborative Group. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J. 2018;39:26\u201335.","journal-title":"Eur Heart J"},{"key":"2855_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10286-024-01064-x","volume":"35","author":"TW Dasari","year":"2025","unstructured":"Dasari TW, Nagai M, Ewbank H, Chakraborty P, Po SS. Heart rate variability metrics and myocardial recovery in heart failure with reduced ejection fraction. Clin Auton Res. 2025;35:115\u201324.","journal-title":"Clin Auton Res"},{"key":"2855_CR28","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.hroo.2025.06.023","volume":"6","author":"M Nagai","year":"2025","unstructured":"Nagai M, Po SS, Scherlag BJ, Dasari TW. Utility of short-term heart rate variability metrics in heart failure with reduced ejection fraction. Heart Rhythm O2. 2025;6:1382\u201390.","journal-title":"Heart Rhythm O2"},{"key":"2855_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1327387","volume":"10","author":"B Vandenberk","year":"2024","unstructured":"Vandenberk B, Haemers P, Morillo C. The autonomic nervous system in atrial fibrillation-pathophysiology and non-invasive assessment. Front Cardiovasc Med. 2024;10:1327387.","journal-title":"Front Cardiovasc Med"},{"key":"2855_CR30","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/s41440-023-01272-4","volume":"46","author":"M Nagai","year":"2023","unstructured":"Nagai M, Dote K, F\u00f6rster CY. Denervation or stimulation? Role of sympathovagal imbalance in HFpEF with hypertension. Hypertens Res. 2023;46:1727\u201337.","journal-title":"Hypertens Res"},{"key":"2855_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.15420\/aer.2020.01","volume":"9","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Po SS, Amil F, Dasari TW. Non-invasive low-level tragus stimulation in cardiovascular diseases. Arrhythm Electrophysiol Rev. 2020;9:40\u201346.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2855_CR32","first-page":"e876","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e876\u2013e894.","journal-title":"Circulation"},{"key":"2855_CR33","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1253\/circj.CJ-25-0002","volume":"89","author":"T Kitai","year":"2025","unstructured":"Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, et al. JCS\/JHFS 2025 Guideline on diagnosis and treatment of heart failure. Circ J. 2025;89:1278\u2013444. Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group.","journal-title":"Circ J"},{"key":"2855_CR34","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1038\/s41440-025-02348-z","volume":"48","author":"YS Isayama","year":"2025","unstructured":"Isayama YS, Matsushima S, Shinohara K, Isayama K, Enzan N, Yamamoto T, et al. Goreisan attenuates cardiac hypertrophy and diastolic dysfunction in heart failure with preserved ejection fraction induced by HFD\/L-NAME via regulation of ICAT-\u03b2-catenin\/ERK axis. Hypertens Res. 2025;48:2882\u201396.","journal-title":"Hypertens Res"},{"key":"2855_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11906-020-01093-7","volume":"22","author":"HE Hicklin","year":"2020","unstructured":"Hicklin HE, Gilbert ON, Ye F, Brooks JE, Upadhya B. Hypertension as a road to treatment of heart failure with preserved ejection fraction. Curr Hypertens Rep. 2020;22:82.","journal-title":"Curr Hypertens Rep"},{"key":"2855_CR36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jacc.2024.11.007","volume":"85","author":"H Lu","year":"2025","unstructured":"Lu H, Kondo T, Claggett BL, Vaduganathan M, Neuen BL, Beldhuis IE, et al. Systolic blood pressure and pulse pressure in heart failure: pooled participant-level analysis of 4 trials. J Am Coll Cardiol. 2025;85:710\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"2855_CR37","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s41440-025-02240-w","volume":"48","author":"C Matsumoto","year":"2025","unstructured":"Matsumoto C, Nagai M, Shinohara K, Morikawa N, Kai H, Arima H. Systolic blood pressure lower than 130 mmHg in heart failure with preserved ejection fraction: a systematic review and meta-analysis of clinical outcomes. Hypertens Res. 2025;48:2138\u201351.","journal-title":"Hypertens Res"},{"key":"2855_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/HCO.0000000000000852","volume":"36","author":"PL Myhre","year":"2021","unstructured":"Myhre PL, Selvaraj S, Solomon SD. Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal? Curr Opin Cardiol. 2021;36:413\u20139.","journal-title":"Curr Opin Cardiol"},{"key":"2855_CR39","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41440-026-02580-1","volume":"49","author":"C Matsumoto","year":"2026","unstructured":"Matsumoto C, Nagai M, Shinohara K, Morikawa N, Kai H, Arima H. JSH 2025 in global perspective: blood pressure management in HFpEF across major guidelines. Hypertens Res. 2026;49:1544\u20138.","journal-title":"Hypertens Res"},{"key":"2855_CR40","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jacc.2008.05.057","volume":"52","author":"S Bangalore","year":"2008","unstructured":"Bangalore S, Wild D, Parkar S, Kukin M, Messerli FH. Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis. J Am Coll Cardiol. 2008;52:1062\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"2855_CR41","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1056\/NEJMoa2512686","volume":"394","author":"AMD Kristensen","year":"2026","unstructured":"Kristensen AMD, Rossello X, Atar D, Yndigegn T, Kimura T, Latini R, et al. Beta-blockers after myocardial infarction with normal ejection fraction. N Engl J Med. 2026;394:540\u201350.","journal-title":"N Engl J Med"},{"key":"2855_CR42","doi-asserted-by":"publisher","first-page":"e1916598","DOI":"10.1001\/jamanetworkopen.2019.16598","volume":"2","author":"DN Silverman","year":"2019","unstructured":"Silverman DN, Plante TB, Infeld M, Callas PW, Juraschek SP, Dougherty GB, et al. Association of \u03b2-blocker use with heart failure hospitalizations and cardiovascular disease mortality among patients with heart failure with a preserved ejection fraction: a secondary analysis of the TOPCAT Trial. JAMA Netw Open. 2019;2:e1916598.","journal-title":"JAMA Netw Open"},{"key":"2855_CR43","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.cardfail.2021.04.015","volume":"27","author":"M Meyer","year":"2021","unstructured":"Meyer M, Du Fay Lavallaz J, Benson L, Savarese G, Dahlstr\u00f6m U, Lund LH. Association between \u03b2-blockers and outcomes in heart failure with preserved ejection fraction: Current insights from the SwedeHF Registry. J Card Fail. 2021;27:1165\u201374.","journal-title":"J Card Fail"},{"key":"2855_CR44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jchf.2023.03.017","volume":"11","author":"SV Arnold","year":"2023","unstructured":"Arnold SV, Silverman DN, Gosch K, Nassif ME, Infeld M, Litwin S, et al. Beta-blocker use and heart failure outcomes in mildly reduced and preserved ejection fraction. JACC Heart Fail. 2023;11:893\u2013900.","journal-title":"JACC Heart Fail"},{"key":"2855_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006213","volume":"12","author":"M Meyer","year":"2019","unstructured":"Meyer M, LeWinter MM. Heart rate and heart failure with preserved ejection fraction: time to slow \u03b2-blocker use? Circ Heart Fail. 2019;12:e006213.","journal-title":"Circ Heart Fail"},{"key":"2855_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.126.26801","volume":"83","author":"JB Cohen","year":"2026","unstructured":"Cohen JB, Hossain A, Chittams J, Zhao M, Afable J, Greenip A, et al. Calcium channel blockade versus \u03b2-blockade for hypertension in heart failure with preserved ejection fraction: a randomized crossover trial. Hypertension. 2026;83:e26801.","journal-title":"Hypertension"},{"key":"2855_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","volume":"9","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O\u2019Brien E, Dobson JE, Dahl\u00f6f B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469\u201380.","journal-title":"Lancet Neurol"},{"key":"2855_CR48","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"Kittleson MM, Panjrath GS, Amancherla K, Davis LL, Deswal A, Dixon DL, et al. 2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023;81:1835\u201378.","journal-title":"J Am Coll Cardiol"},{"key":"2855_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/HCO.0000000000001303","volume":"41","author":"T Fujiwara","year":"2026","unstructured":"Fujiwara T, Kario K. Revisiting the role of beta blockers in the management of hypertension. Curr Opin Cardiol. 2026;41:227\u201335.","journal-title":"Curr Opin Cardiol"},{"key":"2855_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007421","volume":"14","author":"KP Kresoja","year":"2021","unstructured":"Kresoja KP, Rommel KP, Fengler K, von Roeder M, Besler C, L\u00fccke C, et al. Renal sympathetic denervation in patients with heart failure with preserved ejection fraction. Circ Heart Fail. 2021;14:e007421.","journal-title":"Circ Heart Fail"},{"key":"2855_CR51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.010543","volume":"16","author":"KP Rommel","year":"2023","unstructured":"Rommel KP, Pagoulatou S, Kresoja KP, Rosch S, Sch\u00f6ber AR, von Roeder M, et al. Modulation of pulsatile left ventricular afterload by renal denervation in heart failure with preserved ejection fraction. Circ Heart Fail. 2023;16:e010543.","journal-title":"Circ Heart Fail"},{"key":"2855_CR52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008301","volume":"14","author":"M Fudim","year":"2021","unstructured":"Fudim M, Sobotka PA, Piccini JP, Patel MR. Renal denervation for patients with heart failure: Making a full circle. Circ Heart Fail. 2021;14:e008301.","journal-title":"Circ Heart Fail"},{"key":"2855_CR53","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tcm.2022.05.009","volume":"33","author":"M Ahmed","year":"2023","unstructured":"Ahmed M, Nudy M, Bussa R, Hajduczok A, Naccarelli GV, Filippone EJ, et al. A systematic review, meta-analysis, and meta regression of the sham controlled renal denervation randomized controlled trials. Trends Cardiovasc Med. 2023;33:490\u20138.","journal-title":"Trends Cardiovasc Med"},{"key":"2855_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e08847","volume":"8","author":"Z Xia","year":"2022","unstructured":"Xia Z, Han L, Pellegrino PR, Schiller AM, Harrold LD, Lobato RL, et al. Safety and efficacy of renal denervation in patients with heart failure with reduced ejection fraction (HFrEF): a systematic review and meta-analysis. Heliyon. 2022;8:e08847.","journal-title":"Heliyon"},{"key":"2855_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jjcc.2023.01.010","volume":"81","author":"M Li","year":"2023","unstructured":"Li M, Ma W, Fan F, Yi T, Qiu L, Wang Z, et al. Renal denervation in management of heart failure with reduced ejection fraction: a systematic review and meta-analysis. J Cardiol. 2023;81:513\u201321.","journal-title":"J Cardiol"},{"key":"2855_CR56","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2359032","volume":"46","author":"Q Su","year":"2024","unstructured":"Su Q, Li J, Shi F, Yu J. A meta-analysis and review on the effectiveness and safety of renal denervation in managing heart failure with reduced ejection fraction. Ren Fail. 2024;46:2359032.","journal-title":"Ren Fail"},{"key":"2855_CR57","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/ejhf.502","volume":"18","author":"HC Patel","year":"2016","unstructured":"Patel HC, Rosen SD, Hayward C, Vassiliou V, Smith GC, Wage RR, et al. Renal denervation in heart failure with preserved ejection fraction (RDT-PEF): a randomized controlled trial. Eur J Heart Fail. 2016;18:703\u201312.","journal-title":"Eur J Heart Fail"},{"key":"2855_CR58","volume":"5","author":"P Marlecha","year":"2026","unstructured":"Marlecha P, Laffin L, Sangiorgi GM, Sampath A, Mohammed O, Nanjundappa A. C-126 | Renal denervation in heart failure with preserved ejection fraction: a systematic review of randomized controlled trials. J Soc Cardiovasc Angiogr Inter. 2026;5:104860.","journal-title":"J Soc Cardiovasc Angiogr Inter"},{"key":"2855_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.857538","volume":"13","author":"MA Konstam","year":"2022","unstructured":"Konstam MA, Mann DL, Udelson JJE, Ardell JL, De Ferrari GM, Cowie MR, et al. Advances in our clinical understanding of autonomic regulation therapy using vagal nerve stimulation in patients living with heart failure. Front Physiol. 2022;13:857538.","journal-title":"Front Physiol"},{"key":"2855_CR60","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1017\/S0317167100021855","volume":"24","author":"BM Clarke","year":"1997","unstructured":"Clarke BM, Upton AR, Griffin H, Fitzpatrick D, DeNardis M. Chronic stimulation of the left vagus nerve in epilepsy: balance effects. Can J Neurol Sci. 1997;24:230\u20134.","journal-title":"Can J Neurol Sci"},{"key":"2855_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s003810050021","volume":"16","author":"ECG Ventureyra","year":"2000","unstructured":"Ventureyra ECG. Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A N concept Child\u2019s Nerv Syst. 2000;16:101\u20132.","journal-title":"A N concept Child\u2019s Nerv Syst"},{"key":"2855_CR62","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.autneu.2016.06.004","volume":"199","author":"AR Murray","year":"2016","unstructured":"Murray AR, Atkinson L, Mahadi MK, Deuchars SA, Deuchars J. The strange case of the ear and the heart: The auricular vagus nerve and its influence on cardiac control. Auton Neurosci. 2016;199:48\u201353.","journal-title":"Auton Neurosci"},{"key":"2855_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fphys.2019.00025","volume":"10","author":"EM Annoni","year":"2019","unstructured":"Annoni EM, Van Helden D, Guo Y, Levac B, Libbus I, KenKnight BH, et al. Chronic low-level vagus nerve stimulation improves long-term survival in salt-sensitive hypertensive rats. Front Physiol. 2019;10:25.","journal-title":"Front Physiol"},{"key":"2855_CR64","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2337\/db16-0847","volume":"66","author":"CH Malbert","year":"2017","unstructured":"Malbert CH, Picq C, Divoux JL, Henry C, Horowitz M. Obesity-associated alterations in glucose metabolism are reversed by chronic bilateral stimulation of the abdominal vagus nerve. Diabetes. 2017;66:848\u201357.","journal-title":"Diabetes"},{"key":"2855_CR65","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s11695-019-04365-7","volume":"30","author":"F Dai","year":"2020","unstructured":"Dai F, Yin J, Chen JDZ. Effects and mechanisms of vagal nerve stimulation on body weight in diet-induced obese rats. Obes Surg. 2020;30:948\u201356.","journal-title":"Obes Surg"},{"key":"2855_CR66","volume":"17","author":"CA Uma\u00f1a Mejia","year":"2025","unstructured":"Uma\u00f1a Mejia CA, Ascencio Flores CS, Gudi\u00f1o Radilla SG, Laurence Salinas MA, Moreno Alvarez DA, Corona Vargas E, et al. Efficacy of transcutaneous vagus nerve stimulation to suppress paroxysmal atrial fibrillation: a systematic review. Cureus. 2025;17:e86435.","journal-title":"Cureus"},{"key":"2855_CR67","doi-asserted-by":"publisher","first-page":"036011","DOI":"10.1088\/1741-2560\/11\/3\/036011","volume":"11","author":"DT Plachta","year":"2014","unstructured":"Plachta DT, Gierthmuehlen M, Cota O, Espinosa N, Boeser F, Herrera TC, et al. Blood pressure control with selective vagal nerve stimulation and minimal side effects. J Neural Eng. 2014;11:036011.","journal-title":"J Neural Eng"},{"key":"2855_CR68","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1007\/s12325-016-0348-z","volume":"33","author":"DT Plachta","year":"2016","unstructured":"Plachta DT, Zentner J, Aguirre D, Cota O, Stieglitz T, Gierthmuehlen M. Effect of cardiac-cycle-synchronized selective vagal stimulation on heart rate and blood pressure in rats. Adv Ther. 2016;33:1246\u201361.","journal-title":"Adv Ther"},{"key":"2855_CR69","first-page":"3685","volume":"2018","author":"EM Annoni","year":"2018","unstructured":"Annoni EM, Tolkacheva EG. Acute cardiovascular and hemodynamic effects of vagus nerve stimulation in conscious hypertensive rats. Annu Int Conf IEEE Eng Med Biol Soc. 2018;2018:3685\u20138.","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"2855_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.586424","volume":"14","author":"N Ji","year":"2020","unstructured":"Ji N, Lin WH, Chen F, Xu L, Huang J, Li G. Blood pressure modulation with low-intensity focused ultrasound stimulation to the vagus nerve: a pilot animal study. Front Neurosci. 2020;14:586424.","journal-title":"Front Neurosci"},{"key":"2855_CR71","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032269","volume":"13","author":"MB Mbikyo","year":"2024","unstructured":"Mbikyo MB, Wang A, Ma Q, Miao L, Cui N, Yang Y, et al. Low-level tragus stimulation attenuates blood pressure in young individuals with hypertension: Results from a small-scale single-blind controlled randomized clinical trial. J Am Heart Assoc. 2024;13:e032269.","journal-title":"J Am Heart Assoc"},{"key":"2855_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1149449","volume":"17","author":"M Nagai","year":"2023","unstructured":"Nagai M, Dote K, Kato M, Sasaki S, Oda N, F\u00f6rster CY. Afterload reduction after non-invasive vagus nerve stimulation in acute heart failure. Front Hum Neurosci. 2023;17:1149449.","journal-title":"Front Hum Neurosci"},{"key":"2855_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2026.1693086","volume":"13","author":"A Gupta","year":"2026","unstructured":"Gupta A, Collier D, Steckelmacher J, Field J, Zongo O, Patel M, et al. A sham-controlled randomised trial evaluating the safety, acceptability, and efficacy of autonomic neuromodulation using transcutaneous vagal sensory stimulation in uncontrolled hypertensive patients: rationale and study design of the SCRATCH-HTN study. Front Cardiovasc Med. 2026;13:1693086.","journal-title":"Front Cardiovasc Med"},{"key":"2855_CR74","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeaf098","volume":"5","author":"M Nagai","year":"2025","unstructured":"Nagai M, Rommel KP, Nakano Y, Tully PJ, Sible IJ, Po S, et al. Association between non-invasive auricular stimulation and blood pressure lowering: a systematic review and meta-analysis. Eur Heart J Open. 2025;5:oeaf098.","journal-title":"Eur Heart J Open"},{"key":"2855_CR75","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ehf2.12241","volume":"5","author":"LA DiCarlo","year":"2018","unstructured":"DiCarlo LA, Libbus I, Kumar HU, Mittal S, Premchand RK, Amurthur B, et al. Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study. ESC Heart Fail. 2018;5:95\u2013100.","journal-title":"ESC Heart Fail"},{"key":"2855_CR76","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijcard.2023.03.030","volume":"381","author":"HU Kumar","year":"2023","unstructured":"Kumar HU, Nearing BD, Mittal S, Premchand RK, Libbus I, DiCarlo LA, et al. Autonomic regulation therapy in chronic heart failure with preserved\/mildly reduced ejection fraction: aNTHEM-HFpEF study results. Int J Cardiol. 2023;381:37\u201344.","journal-title":"Int J Cardiol"},{"key":"2855_CR77","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12265-018-9853-6","volume":"12","author":"N Tran","year":"2019","unstructured":"Tran N, Asad Z, Elkholey K, Scherlag BJ, Po SS, Stavrakis S. Autonomic neuromodulation acutely ameliorates left ventricular strain in humans. J Cardiovasc Transl Res. 2019;12:221\u201330.","journal-title":"J Cardiovasc Transl Res"},{"key":"2855_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.999831","volume":"16","author":"M Nagai","year":"2022","unstructured":"Nagai M, Dote K, Kato M, Sasaki S, Oda N, F\u00f6rster CY. Case report: SGLT2i, transcutaneous vagus nerve stimulation, and their effects on intrarenal venous flow pattern in HFpEF. Front Neurosci. 2022;16:999831.","journal-title":"Front Neurosci"},{"key":"2855_CR79","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jacep.2019.11.008","volume":"6","author":"S Stavrakis","year":"2020","unstructured":"Stavrakis S, Stoner JA, Humphrey MB, Morris L, Filiberti A, Reynolds JC, et al. TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): a randomized Clinical trial. JACC Clin Electrophysiol. 2020;6:282\u201391.","journal-title":"JACC Clin Electrophysiol"},{"key":"2855_CR80","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.cardfail.2020.12.017","volume":"27","author":"TW Dasari","year":"2021","unstructured":"Dasari TW, Csipo T, Amil F, Lipecz A, Fulop GA, Jiang Y, et al. Effects of low-level tragus stimulation on endothelial function in heart failure with reduced ejection fraction. J Card Fail. 2021;27:568\u201376.","journal-title":"J Card Fail"},{"key":"2855_CR81","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.009288","volume":"15","author":"K Elkholey","year":"2022","unstructured":"Elkholey K, Niewiadomska M, Morris L, Whyte S, Houser J, Humphrey MB, et al. Transcutaneous vagus nerve stimulation ameliorates the phenotype of heart failure with preserved ejection fraction through its anti-inflammatory effects. Circ Heart Fail. 2022;15:e009288.","journal-title":"Circ Heart Fail"},{"key":"2855_CR82","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s12265-024-10544-4","volume":"17","author":"M Nagai","year":"2024","unstructured":"Nagai M, Dote K, Kato M, Sasaki S, Oda N, Po SS, et al. Blood pressure variability after non-invasive low-level tragus stimulation in acute heart failure. J Cardiovasc Transl Res. 2024;17:1347\u201352.","journal-title":"J Cardiovasc Transl Res"},{"key":"2855_CR83","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ajh\/hpaf164","volume":"39","author":"M Nagai","year":"2026","unstructured":"Nagai M, Dote K, Kato M, Sasaki S, Oda N, Po SS, et al. Central pressure variability after low-level tragus stimulation in acute decompensated heart failure. Am J Hypertens. 2026;39:208\u201313.","journal-title":"Am J Hypertens"},{"key":"2855_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.70534","volume":"63","author":"M Nagai","year":"2026","unstructured":"Nagai M, Umeda S, Ewbank H, Saleh Velez FG, Po S, Dasari T. Interoception, immunoception, and the role of insular cortex in cardiovascular disease. Eur J Neurosci. 2026;63:e70534.","journal-title":"Eur J Neurosci"},{"key":"2855_CR85","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023582","volume":"11","author":"S Stavrakis","year":"2022","unstructured":"Stavrakis S, Elkholey K, Morris L, Niewiadomska M, Asad ZUA, Humphrey MB. Neuromodulation of inflammation to treat heart failure with preserved ejection fraction: a pilot randomized clinical trial. J Am Heart Assoc. 2022;11:e023582.","journal-title":"J Am Heart Assoc"},{"key":"2855_CR86","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12872-025-04919-x","volume":"25","author":"Z Sun","year":"2025","unstructured":"Sun Z, Liu L, Peng H, Zhang R. The efficacy of transcutaneous vagus nerve stimulation in heart failure management - a systematic review and meta-analysis. BMC Cardiovasc Disord. 2025;25:481.","journal-title":"BMC Cardiovasc Disord"},{"key":"2855_CR87","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jash.2011.03.001","volume":"5","author":"M Nagai","year":"2011","unstructured":"Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: New independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens. 2011;5:184\u201392.","journal-title":"J Am Soc Hypertens"},{"key":"2855_CR88","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10286-024-01074-9","volume":"35","author":"F Gentile","year":"2025","unstructured":"Gentile F, Giannoni A, Navari A, Degl\u2019Innocenti E, Emdin M, Passino C. Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure. Clin Auton Res. 2025;35:75\u201385.","journal-title":"Clin Auton Res"},{"key":"2855_CR89","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14797\/mdcvj.1516","volume":"21","author":"J Na","year":"2025","unstructured":"Na J, Garapati SS, Lador A. Obesity and atrial fibrillation: a comprehensive review. Methodist Debakey Cardiovasc J. 2025;21:35\u201343.","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"2855_CR90","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.jacc.2025.08.036","volume":"86","author":"M Packer","year":"2025","unstructured":"Packer M, Butler J, Lam CSP, Zannad F, Vaduganathan M, Borlaug BA. Central adiposity or hypertension: Which drives heart failure with a preserved ejection fraction? J Am Coll Cardiol. 2025;86:1935\u201349.","journal-title":"J Am Coll Cardiol"},{"key":"2855_CR91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/eurheartj\/ehaf645","volume":"47","author":"M Packer","year":"2026","unstructured":"Packer M. Do obesity and visceral adiposity promote heart failure with reduced ejection fraction? Eur Heart J. 2026;47:12\u201321.","journal-title":"Eur Heart J"},{"key":"2855_CR92","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1161\/CIRCULATIONAHA.126.079235","volume":"154","author":"M Packer","year":"2026","unstructured":"Packer M, Schiattarella GG, Petrie MC, Burkhoff D, Butler J, Lam CSP, et al. Does characterization of phenotypic heterogeneity provide mechanistic insights or influence the response to treatment? Experience in positive and neutral trials in patients with heart failure and a preserved ejection fraction. Circulation. 2026;154:271\u201387.","journal-title":"Circulation"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02855-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02855-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02855-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:02:01Z","timestamp":1791586921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02855-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":92,"alternative-id":["2855"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02855-7","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"30 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}